• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Feds push states to abolishcertificate of need regs

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 12
Volume 30
Issue 12

The U.S. Department of Justice and theFederal Trade Commission are pressuring stategovernments to repeal certificate of need lawsmeant to control healthcare costs by regulatingthe purchase of capital equipment, suchas MRI technology and CT scanners.

The U.S. Department of Justice and the Federal Trade Commission are pressuring state governments to repeal certificate of need laws meant to control healthcare costs by regulating the purchase of capital equipment, such as MRI technology and CT scanners.

The two agencies argue that CON laws are anticompetitive, favor incumbents, and undercut consumer choice. The DOJ and FTC underscored their position in discussions with Georgia and in statements to Alaska, Florida, and, more recently, Illinois.

At the invitation of Gov. Sarah Palin of Alaska, FTC officials testified in February at a state legislative committee in favor of HB 337, a bill that would have eliminated CON jurisdiction in several cities and towns. The bill's opponents say deregulation will favor privately owned specialty hospitals at the expense of the state's acute care hospitals. Efforts to pass the bill have so far been stymied.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.